Chemical Works (RICHT.BD)
ValueMarkers Composite Index
36% below intrinsic value ($61)
Chemical Works (RICHT.BD) — VMCI valuation read
RICHT.BD prints VMCI 67/100 inside the Healthcare sector, where the median sits at 50. The 17-point above-median delta is the cleanest single-number summary of Chemical Works's composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.
On RICHT.BD, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.
**Investor frame.** RICHT.BD trades at 16.0x earnings, 11% below the Healthcare median of 18.0x; that is the value line. ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 1.3x leaves covenant headroom; that is the risk line for Chemical Works on the trailing financials.
RICHT.BD fell 4.0% over the trailing 7 days, with a -19.7% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.